コンピテントセルの市場規模、シェア、成長分析、タイプ別、用途別、エンドユーザー別、地域別 - 産業予測、2025～2032年

コンピテントセルの世界市場規模は2023年に21億3,000万米ドルと評価され、予測期間（2025-2032年）のCAGRは8.1%で、2024年の23億米ドルから2032年には42億9,000万米ドルに成長する見通しです。

世界のコンピテントセル市場は、分子クローニング研究に対する官民両部門からの投資の増加により、大きな成長を遂げています。大腸菌は、塩化カルシウムと熱ショックを含む技術によって染色体外DNAを統合するユニークな能力を有しており、研究者にとって魅力的です。これらの方法は透過性の細胞壁を作り、様々な用途に不可欠なDNA形質転換を容易にします。さらに、ヘルスケア支出の増加やこうしたソリューションに対する意識の高まりと相まって、分子クローン製品に対する消費者の需要が高まっていることも、市場の拡大をさらに後押ししています。研究資金と人口増加を支援する政府の取り組みも市場のダイナミクスにプラスに寄与しており、有能細胞技術の革新と開発のための強固な環境を裏付けています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術分析
• 規制分析
• 特許分析
• ケーススタディ

コンピテントセル市場規模：タイプ別

• 市場概要
• 化学的コンピテントセル
• エレクトロコンピテントセル

コンピテントセル市場規模：用途別

• 市場概要
• クローン
• サブクローニングとルーチンクローニング
• ファージディスプレイライブラリの構築
• 有毒/不安定DNAクローニング
• ハイスループットクローニング
• タンパク質発現
• その他の用途
• 突然変異誘発
• 一本鎖DNAの生成
• レンチウイルスベクターの生産
• 大きなプラスミド変換

コンピテントセル市場規模：エンドユーザー別

• 市場概要
• 製薬・バイオテクノロジー企業
• 学術調査機関
• 契約調査機関（CRO）

コンピテントセル市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Merck KGaA（Germany）
• Promega Corporation（US）
• Thermo Fisher Scientific, Inc.（US）
• New England Biolabs（US）
• Takara Bio（Japan）
• Agilent Technologies（US）
• Lucigen（Epicenter）（Illumina）（US）
• QIAGEN N.V.（Germany）
• OriGene Technologies（US）
• Bioline（UK）
• Zymo Research（US）
• Beijing TransGen Biotech Co., Ltd.（China）
• Source BioScience（UK）
• IBA GmbH（Germany）
• Genewiz（US）
• BioDynamics Laboratory, Inc.（Japan）
• GCC Biotech（India）
• SMOBIO Technology（Taiwan）
• GeneScript Corporation（US）
• Bio-Rad Laboratories（US）

結論と推奨事項

Global Competent Cells Market size was valued at USD 2.13 billion in 2023 and is poised to grow from USD 2.3 billion in 2024 to USD 4.29 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The global competent cells market is experiencing significant growth, driven by increased investments from both public and private sectors in molecular cloning research. E. coli's unique ability to integrate extrachromosomal DNA through techniques involving calcium chloride and heat shock is compelling for researchers. These methods create permeable cell walls, facilitating DNA transformation essential for various applications. Additionally, rising consumer demand for molecularly cloned products, coupled with growing healthcare expenditures and heightened awareness of these solutions, further bolsters market expansion. Government initiatives supporting research funding and population growth also contribute positively to the market's dynamics, underscoring a robust environment for innovation and development in competent cell technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Competent Cells market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Competent Cells Market Segmental Analysis

Global Competent Cells Market is segmented by Type, Application, End User and region. Based on Type, the market is segmented into Chemically Competent Cells and Electrocompetent Cells. Based on Application, the market is segmented into Cloning, Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, High-throughput Cloning, Protein Expression, Other Applications, Mutagenesis, Single-stranded DNA Production, Lentiviral Vector Production and Large Plasmid Transformation. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Competent Cells Market

The global competent cells market is poised for growth, largely propelled by favorable government initiatives and the surging demand for products developed through recombinant DNA technology, alongside advancements in molecular engineering. Over the coming years, this market is expected to thrive due to heightened research and development efforts aimed at creating therapeutic items addressing various health conditions, coupled with beneficial reimbursement and regulatory frameworks. Furthermore, a growing commercial interest in molecularly cloned products and recombinant proteins, alongside increased government investment in research activities, is anticipated to significantly enhance market potential throughout the next decade.

Restraints in the Global Competent Cells Market

The Global Competent Cells market is likely to face several constraints hindering its growth. One significant factor is the high cost associated with competent cell kits, which can deter potential market entrants and limit accessibility for smaller research facilities. Furthermore, the increasing market consolidation is raising entry barriers, making it challenging for new players to compete. Compounding these issues, a shortage of skilled professionals with expertise in this field is expected to pose an additional challenge during the forecast period, ultimately impeding the overall expansion of the competent cells market.

Market Trends of the Global Competent Cells Market

The Global Competent Cells market is poised for significant growth, driven by the rising demand for molecular cloning applications across various sectors. Increasing investments in cloning research, coupled with financial support from governmental and private organizations, are propelling advancements in cell engineering techniques like somatic cell nuclear transfer (SCNT). These technologies are pivotal in producing transgenic animals, preserving endangered species, and advancing therapeutic cloning. As competent cells play a crucial role in these innovative research areas, the market is expected to attract renewed interest and investment, resulting in a robust upward trend in demand for competent cells worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis
• Patent Analysis
• Case Studies

Global Competent Cells Market Size by Type & CAGR (2025-2032)

• Market Overview
• Chemically Competent Cells
• Electrocompetent Cells

Global Competent Cells Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cloning
• Subcloning & Routine Cloning
• Phage Display Library Construction
• Toxic/Unstable DNA Cloning
• High-throughput Cloning
• Protein Expression
• Other Applications
• Mutagenesis
• Single-stranded DNA Production
• Lentiviral Vector Production
• Large Plasmid Transformation

Global Competent Cells Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical and Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations (CROs)

Global Competent Cells Market Size & CAGR (2025-2032)

• North America (Type, Application, End User)
  • US
  • Canada
• Europe (Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lucigen (Epicenter) (Illumina) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioline (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zymo Research (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing TransGen Biotech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Source BioScience (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBA GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genewiz (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioDynamics Laboratory, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GCC Biotech (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SMOBIO Technology (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneScript Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations